The (-765 G→C) promoter variant of the COX-2/PTGS2 gene is associated with a lower risk for end-stage hip and knee osteoarthritis

Annals of the Rheumatic Diseases

Volumn 70, Issue 8, 2011, Pages 1458-1460

  Schneider, E M ^a   Du, W ^a   Fiedler, J ^a   Hogel J ^b   Gunther K P ^c   Brenner, H ^d   Brenner, R E ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERMANY; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHONDROCYTES; CYCLOOXYGENASE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 78650968063     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.124040     Document Type: Article

References (20)

1. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009;11:227.
2. Spector TD, MacGregor AJ. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage 2004;12(Suppl A):S39-44.
3. Valdes AM, Doherty M, Spector TD. The additive effect of individual genes in predicting risk of knee osteoarthritis. Ann Rheum Dis 2008;67:124-7.
4. Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004;(427 Suppl):S37-46.
5. Attur M, Al-Mussawir HE, Patel J, et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 2008;181:5082-8.
6. Valdes AM, Van Oene M, Hart DJ, et al. Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum 2006;54:533-9. (Pubitemid 43228629)
7. Valdes AM, Loughlin J, Timms KM, et al. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet 2008;82:1231-40.
8. Papafili A, Hill MR, Brull DJ, et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002;22:1631-6.
9. Günther KP, Stürmer T, Sauerland S, et al. Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study. Ann Rheum Dis 1998;57:717-23. (Pubitemid 29009683)
10. Stürmer T, Günther KP, Brenner H. Obesity, overweight and patterns of osteoarthritis: the Ulm Osteoarthritis Study. J Clin Epidemiol 2000;53:307-13. (Pubitemid 30173251)
11. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
12. Skarke C, Schuss P, Kirchhof A, et al. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Pharmacogenomics 2007;8:1643-60.
13. Upadhyay R, Jain M, Kumar S, et al. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res 2009;663:52-9.
14. Ryder JJ, Garrison K, Song F, et al. Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: a systematic review. Ann Rheum Dis 2008;67:584-91. (Pubitemid 351571919)
15. Cipollone F, Toniato E, Martinotti S, et al. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004;291:2221-8. (Pubitemid 38608171)
16. Abdullah L, Ait-Ghezala G, Crawford F, et al. The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer's disease. Neurosci Lett 2006;395:240-3. (Pubitemid 43213153)
17. Lee KH, Kim HS, El-Sohemy A, et al. Cyclooxygenase-2 genotype and rheumatoid arthritis. J Rheumatol 2006;33:1231-4. (Pubitemid 44025131)
18. Ho YP, Lin YC, Yang YH, et al. Cyclooxygenase-2 Gene-765 single nucleotide polymorphism as a protective factor against periodontitis in Taiwanese. J Clin Periodontol 2008;35:1-8.
19. Hill MR, Papafili A, Booth H, et al. Functional prostaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006;174:915-22. (Pubitemid 44564792)
20. de Boer TN, Huisman AM, Polak AA, et al. The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthritis Cartilage 2009;17:482-8.